CMS to cover new valve replacement technology

The Centers for Medicare & Medicaid Services announced Tuesday that transcatheter aortic valve replacement (TAVR), a less-invasive approach to treat aortic stenosis, will be covered for Medicare patients under certain conditions because the technology is new. Using “coverage with evidence development” as a condition will require that specified physician, facility and data collection be met to ensure patient safety.

Previously, repairing damaged heart valves was only accomplished through invasive surgery. TAVR technology allows physicians to replace an aortic valve via a catheter inserted through a small opening in the leg. 

“This decision is particularly important as it highlights cooperative efforts among CMS, the Food and Drug Administration, medical specialty societies and the medical device industry,” said CMS Acting Administrator Marilyn Tavenner, in a press release.

I Advance Senior Care

I Advance Senior Care is the industry-leading source for practical, in-depth, business-building, and resident care information for owners, executives, administrators, and directors of nursing at assisted living communities, skilled nursing facilities, post-acute facilities, and continuing care retirement communities. The I Advance Senior Care editorial team and industry experts provide market analysis, strategic direction, policy commentary, clinical best-practices, business management, and technology breakthroughs.

I Advance Senior Care is part of the Institute for the Advancement of Senior Care and published by Plain-English Health Care.